![Henrik Luer Lueßen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henrik Luer Lueßen
Direttore/Membro del Consiglio presso Alvotech Germany GmbH
Posizioni attive di Henrik Luer Lueßen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Alvotech Germany GmbH
![]() Alvotech Germany GmbH BiotechnologyHealth Technology Baliopharm GmbH operates as biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 and is headquartered in Juelich, Germany. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Henrik Luer Lueßen
Precedenti posizioni note di Henrik Luer Lueßen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | - | 16/01/2006 |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Fondatore | 01/04/2015 | - |
Corporate Officer/Principal | 01/04/2015 | - | |
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Paesi Bassi | 3 |
Germania | 3 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Founder | 1 |
Settori
Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Health Technology |
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Alvotech Germany GmbH
![]() Alvotech Germany GmbH BiotechnologyHealth Technology Baliopharm GmbH operates as biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 and is headquartered in Juelich, Germany. | Health Technology |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Henrik Luer Lueßen
- Esperienza